Free Trial

Starpharma (SPHRY) Short Interest Ratio & Short Volume

Starpharma logo
$0.74 +0.06 (+8.86%)
(As of 11/14/2024 ET)

Starpharma Short Interest Data

Starpharma (SPHRY) has a short interest of 4,500 shares. This marks a 66.67% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.8, indicating that it would take 0.8 days of the average trading volume of 2,925 shares to cover all short positions.

Current Short Interest
4,500 shares
Previous Short Interest
2,700 shares
Change Vs. Previous Month
+66.67%
Dollar Volume Sold Short
$2,677.50
Short Interest Ratio
0.8 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
41,811,000 shares
Percentage of Shares Shorted
0.01%
Today's Trading Volume
9,306 shares
Average Trading Volume
2,925 shares
Today's Volume Vs. Average
318%
Short Selling Starpharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Starpharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

SPHRY Short Interest Over Time

SPHRY Days to Cover Over Time

SPHRY Percentage of Float Shorted Over Time

Starpharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/20244,500 shares $2,677.50 +66.7%N/A0.8 $0.60
10/15/20242,700 shares $1,597.32 No ChangeN/A3.9 $0.59
9/30/20242,700 shares $2,052.00 No ChangeN/A1 $0.76
9/15/20242,700 shares $1,755.00 No ChangeN/A13.5 $0.65
8/31/20242,700 shares $1,404.27 -25.0%N/A3.9 $0.52
8/15/20243,600 shares $2,066.40 No ChangeN/A36 $0.57
7/31/20243,600 shares $2,232.00 -20.0%N/A2.8 $0.62
7/15/20244,500 shares $2,700.00 -18.2%N/A11.3 $0.60
6/30/20245,500 shares $3,465.69 +96.4%N/A2.5 $0.63
6/15/20242,800 shares $1,958.04 No ChangeN/A7.1 $0.70
5/31/20242,800 shares $2,339.68 No ChangeN/A1.3 $0.84
5/15/20242,800 shares $2,023.00 +21.7%N/A4 $0.72
4/30/20242,300 shares $2,070.00 -14.8%N/A1 $0.90
4/15/20242,700 shares $2,322.00 No ChangeN/A1.5 $0.86
3/31/20242,700 shares $2,214.00 -70.0%N/A1.9 $0.82
3/15/20249,000 shares $7,830.00 +12.5%N/A0.7 $0.87
2/29/20248,000 shares $7,601.60 +9.6%N/A2.7 $0.95
2/15/20247,300 shares $6,935.00 -7.6%N/A3.7 $0.95
1/15/20248,200 shares $8,446.00 -4.7%N/A10.2 $1.03
12/31/20238,600 shares $10,698.40 +45.8%N/A2.4 $1.24
12/15/20235,900 shares $5,510.01 +78.8%N/A1.2 $0.93
11/30/20233,300 shares $3,234.00 -37.7%N/A0.9 $0.98
11/15/20235,300 shares $0.00 No ChangeN/A13.3 $0.00
10/31/20235,300 shares $4,858.51 +140.9%N/A4.1 $0.92
10/15/20232,200 shares $2,024.00 -50.0%N/A1.2 $0.92
9/30/20234,400 shares $4,774.00 +10.0%N/A2.3 $1.09
9/15/20234,000 shares $3,580.40 -16.7%N/A0.5 $0.90
8/31/20234,800 shares $4,656.00 +84.6%N/A0.9 $0.97
8/15/20232,600 shares $2,834.00 No ChangeN/A0.5 $1.09
6/15/2023200 shares $520.00 No ChangeN/A0.4 $2.60
5/31/2023200 shares $580.00 No ChangeN/A2 $2.90
5/15/2023200 shares $608.00 +100.0%N/A0.2 $3.04
4/30/2023100 shares $325.00 No ChangeN/A0.1 $3.25
4/15/2023100 shares $307.00 No ChangeN/A0.1 $3.07
3/31/2023100 shares $318.00 No ChangeN/A0.1 $3.18
3/15/2023100 shares $306.00 No ChangeN/A0.1 $3.06
2/28/2023100 shares $350.00 No ChangeN/A0.3 $3.50
2/15/2023100 shares $387.00 -50.0%N/A0.5 $3.87
1/31/2023200 shares $924.00 -33.3%N/A0.4 $4.62
1/15/2023300 shares $1,381.68 No ChangeN/A0.1 $4.61
Trump Wins… But Elon Says Get Ready to Brace (Ad)

Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…

Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov
12/30/2022300 shares $1,092.00 No ChangeN/A0.1 $3.64
12/15/2022300 shares $1,035.00 -40.0%N/A0.2 $3.45
11/30/2022500 shares $1,775.00 -16.7%N/A0.6 $3.55
11/15/2022600 shares $2,310.00 No ChangeN/A0.5 $3.85
10/31/2022600 shares $2,082.00 -45.5%N/A0.5 $3.47
10/15/20221,100 shares $4,543.00 No ChangeN/A0.3 $4.13
9/15/2022100 shares $405.00 No ChangeN/A0 $4.05
5/15/2022500 shares $2,700.00 No ChangeN/A0.4 $5.40
11/30/2021700 shares $5,285.00 -46.2%N/A0.2 $7.55
11/15/20211,300 shares $10,010.00 -51.9%N/A0.4 $7.70
10/29/20212,700 shares $21,303.00 +8.0%N/A0.6 $7.89
10/15/20212,500 shares $22,125.00 +92.3%N/A2.3 $8.85
9/30/20211,300 shares $11,973.13 -31.6%N/A0.6 $9.21
9/15/20211,900 shares $18,259.00 -17.4%N/A0.4 $9.61
8/31/20212,300 shares $20,700.00 No ChangeN/A0.5 $9.00
7/30/2021300 shares $3,048.00 +200.0%N/A0 $10.16
7/15/2021100 shares $1,005.00 -94.4%N/A0 $10.05
6/30/20211,800 shares $20,160.00 +157.1%N/A0.5 $11.20
6/15/2021700 shares $8,998.50 +75.0%N/A0.6 $12.86
5/28/2021400 shares $5,104.00 -55.6%N/A0.4 $12.76
5/14/2021900 shares $11,610.00 No ChangeN/A0.5 $12.90
4/15/2021200 shares $3,000.00 -83.3%N/A0.1 $15.00
3/31/20211,200 shares $18,900.00 +33.3%N/A0.6 $15.75
3/15/2021900 shares $13,014.00 +800.0%N/A0.3 $14.46
2/26/2021100 shares $1,720.00 -91.7%N/A0 $17.20
2/12/20211,200 shares $18,660.00 +1,100.0%N/A0.2 $15.55
1/29/2021100 shares $1,157.00 -75.0%N/A0.1 $11.57
12/31/2020800 shares $9,840.00 No ChangeN/A0.1 $12.30
11/30/20201,300 shares $12,974.00 -18.8%N/A0.5 $9.98
11/15/20201,600 shares $15,200.00 No ChangeN/A0.6 $9.50
10/15/20203,300 shares $36,217.50 -23.3%N/A1 $10.98
9/30/20204,300 shares $46,440.00 +168.8%N/A1.2 $10.80
9/15/20201,600 shares $19,808.00 -36.0%N/A0.2 $12.38
8/31/20202,500 shares $27,525.00 +66.7%N/A0.5 $11.01
8/14/20201,500 shares $11,070.00 +275.0%N/A0.6 $7.38
7/31/2020400 shares $3,000.00 -77.8%N/A0.4 $7.50
7/15/20201,800 shares $14,085.00 -21.7%N/A0.8 $7.83
6/30/20202,300 shares $18,699.00 No ChangeN/A1 $8.13
6/15/20202,300 shares $16,100.00 -20.7%N/A2.6 $7.00
5/29/20202,900 shares $20,155.00 No ChangeN/A2.6 $6.95
5/15/20202,900 shares $17,980.00 +45.0%N/A0.9 $6.20
4/30/20202,000 shares $13,200.00 +233.3%N/A0.5 $6.60
4/15/2020600 shares $3,570.00 -50.0%N/A0.4 $5.95
3/31/20201,200 shares $6,000.00 +140.0%N/A0.4 $5.00
3/13/2020500 shares $2,950.00 -28.6%N/A0.2 $5.90
2/28/2020700 shares $4,662.00 +600.0%N/A0.3 $6.66
2/14/2020100 shares $620.00 No ChangeN/A0.2 $6.20
1/31/2020100 shares $780.00 No ChangeN/A0 $7.80
12/31/2019300 shares $2,454.00 +50.0%N/A0.6 $8.18

SPHRY Short Interest - Frequently Asked Questions

What is Starpharma's current short interest?

Short interest is the volume of Starpharma shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 4,500 shares of SPHRY short. Learn More on Starpharma's current short interest.

What is a good short interest ratio for Starpharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SPHRY shares currently have a short interest ratio of 1.0. Learn More on Starpharma's short interest ratio.

Is Starpharma's short interest increasing or decreasing?

Starpharma saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 4,500 shares, an increase of 66.7% from the previous total of 2,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Starpharma's short interest compare to its competitors?

Here is how the short interest of companies compare to Starpharma: Inotiv, Inc. (5.83%), Luna Innovations Incorporated (5.97%), Auxly Cannabis Group Inc. (0.01%), OneMedNet Co. (1.73%), bioAffinity Technologies, Inc. (3.69%), iSpecimen Inc. (5.44%), IQVIA Holdings Inc. (1.47%), ICON Public Limited (1.32%), Incyte Co. (3.90%), Medpace Holdings, Inc. (4.31%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Starpharma stock?

Short selling SPHRY is an investing strategy that aims to generate trading profit from Starpharma as its price is falling. SPHRY shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Starpharma?

A short squeeze for Starpharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SPHRY, which in turn drives the price of the stock up even further.

How often is Starpharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SPHRY, twice per month. The most recent reporting period available is October, 31 2024.




This page (OTCMKTS:SPHRY) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners